|Year : 2018 | Volume
| Issue : 2 | Page : 64-74
A randomised comparative study to evaluate the efficacy of homoeopathic treatment -vs- standard allopathy treatment for acute adenolymphangitis due to lymphatic filariasis
Jaya Gupta1, Raj K Manchanda1, Lipi Pushpa Debata2, Gupta Payal1, Sujata Choudhary3, Akshaya Prusty3, Goutam Rakshit1, Vikram Singh1, Arvind Kumar1, Chetna Deep Lamba1
1 Central Council for Research in Homoeopathy, New Delhi, India
2 Homoeopathic Drug Research Institute, Lucknow, Uttar Pradesh, India
3 Regional Research Institute, Puri, India
|Date of Submission||21-Jul-2017|
|Date of Acceptance||11-Jun-2018|
|Date of Web Publication||2-Jul-2018|
Dr. Jaya Gupta
Central Council for Research in Homoeopathy, New Delhi
Source of Support: None, Conflict of Interest: None
Objective: The primary objective of the study was to compare the effectiveness of homoeopathic treatment with standard allopathic regimen in acute ADL and secondary objective was to assess the reduction in frequency, duration and intensity of subsequent attacks, improvement of the quality of life of patients. Methods: The study was designed as a comparative randomized trial conducted from October 2012 to April 2014, on 112 patients at Regional Research Institute, Puri, Odisha. The ADL patients enrolled were randomized to receive either homoeopathic treatment or standard allopathic treatment for a period of six months. The outcome parameters used were ADL score and WHO QOL Bref. Results: 112 Patients were considered for primary outcome analysis as per the Intention to treat principle. (Homoeopathy= 55 and Allopathy= 57) and were analysed on 11th day of treatment. Both the treatments produced equal improvement in ADL scores. However, during the six months study period, the frequency, duration and intensity of attacks were better in Homoeopathy group compared to allopathy group. There was statistically significant improvement in Homoeopathy for Domain 4 of WHOQOL (P = 0.004) as compared to allopathy group. Medicines like Apismellifica (n = 23), Rhus toxicodendron (n = 20), Pulsatilla (n = 8), Arsenic album (n = 1), Bryonia alba (n = 1), Silicea (n = 1) and Hepar sulph (n = 1) were found most useful in the acute attacks. Conclusion: This study provides evidence to support the fact that individualized homoeopathy treatment is equally effective for ADL as the standard allopathy treatment in the management of ADL.
Keywords: Adenolymphangitis, Allopathy, Homoeopathy, Lymphatic filariasis, Randomised controlled trial
|How to cite this article:|
Gupta J, Manchanda RK, Debata LP, Payal G, Choudhary S, Prusty A, Rakshit G, Singh V, Kumar A, Lamba CD. A randomised comparative study to evaluate the efficacy of homoeopathic treatment -vs- standard allopathy treatment for acute adenolymphangitis due to lymphatic filariasis. Indian J Res Homoeopathy 2018;12:64-74
|How to cite this URL:|
Gupta J, Manchanda RK, Debata LP, Payal G, Choudhary S, Prusty A, Rakshit G, Singh V, Kumar A, Lamba CD. A randomised comparative study to evaluate the efficacy of homoeopathic treatment -vs- standard allopathy treatment for acute adenolymphangitis due to lymphatic filariasis. Indian J Res Homoeopathy [serial online] 2018 [cited 2021 Jun 20];12:64-74. Available from: https://www.ijrh.org/text.asp?2018/12/2/64/235798
| Introduction|| |
Lymphatic filariasis (LF) is a vector-borne disease of the tropical and subtropical countries caused by parasite; the nematode species include mostly Wuchereria bancrofti (90%), to a lesser extent, Brugia malayi (10%) and Brugia timori to a very small extent. The genera of mosquitoes transmitting these parasites include Culex, Anopheles, Aedes or Mansonia. Globally, around 120 million people in around 83 countries are affected; it is ranked as the second most common cause of physical disability.
In endemic countries, it is the most common cause of lymphoedema, which mostly affects the lower limbs, sometimes the arms, less commonly male genitalia and rarely breasts and female genitals. Several studies have documented the physical, social, psychological, sexual and economic problems resulting not only from the deformities caused by LF but also from the acute febrile episodes associated with this disease.
Human LF caused by W. bancrofti is highly prevalent in India. Even though this disease does not prove to be fatal, it causes considerable morbidity in the affected community.
LF is associated with a wide range of clinical signs, symptoms and sequelae, which are influenced by a variety of factors related to host and parasite. Acute episodes of adenolymphangitis (ADL) is one of the symptoms, which is characterised by recurrent attacks of fever associated with inflammation of the lymph nodes and or lymph vessels. It is characterised by the sudden onset of high fever, lymphangitis, lymphadenitis and transient local oedema. Generalised symptoms include fever along with headache, chills, nausea, vomiting and loss of appetite. The lymphangitis is retrograde, extending peripherally from the lymph node draining the area where the adult parasites reside. This nature of filaria-induced lymphangitis distinguishes it from bacteria-induced one. Generalised symptoms include fever along with headache, chills, nausea, vomiting and loss of appetite. Regional lymph nodes are enlarged, and the entire lymphatic channel can become indurated and inflamed. Acute attacks can occur in people with or without detectable microfilaraemia and are common in people with chronic disease. These episodes interrupt normal activities, often confining them to bed.,
The importance of acute clinical manifestations, i.e. ADL, in natural progression of the disease, particularly the development of chronic disease has been recognised by filarialogists. Although the need of systematic epidemiological studies on acute LF or ADL is recognised, a few studies have been undertaken in different endemic areas.
In a study conducted to measure physical and psychological burden caused by LF, it was found that even though lymphoedema and hydrocele caused severe and permanent disabilities to the patients, the severity of disabilities caused by ADL was greatest. Pain and discomfort interfered with all activities. Physical incapacitation in the most productive stage of life, financial problems, dependency on others and inability to lead a normal life gradually affects the mental health of the individual and leads to anxiety and depression.,,,
Till date, antifilarial drug like Diethylcarbamazine (DEC) is the standard treatment of choice for filaria, but administration of this drug can lead to some short-term adverse reactions such as fever, headache, myalgia, vomiting and even asthma. With Homoeopathy, this kind of distress can be prevented.
According to the WHO, LF exerts a heavy social burden because of the specific attributes of the disease, particularly since chronic complications are often hidden and are considered shameful. For men, genital damage is a severe handicap leading to physical limitations and social stigmatisation. For women, shame and taboos are also associated with the disease. When affected by lymphoedema, they are considered undesirable, and when their lower limbs and genital parts are enlarged, they are severely stigmatised; marriage, in many situations, an essential source of security, is often impossible.
Gyapong et al.[11) reasoned that many ADL patients might not have found available treatment options very useful, and most knew that episodes would be over in a week or less. Non-treatment of ADL episodes may result in chronic LF, with its concomitant social and economic burdens and functional impairment and disability.
Central Council for Research in Homoeopathy (CCRH) undertook a multicentric open clinical trial for evaluating usefulness of homoeopathic medicines in filariasis between 1980 and 2003. However, the study lacked the currently available diagnostic tests and a proper valid scoring scale. It was, therefore, necessary to carry out a randomised open controlled clinical trial of predefined homoeopathic medicines on ADL due to LF on a set protocol with clear outcome parameters.
The primary objective of the study was to assess the effectiveness of homoeopathic medicines in acute ADL attack, as compared to standard allopathic medicines, as evident from the ADL scoring scale, assessed at baseline on day 1 to 11th day of treatment [Annexure 1].
The secondary objective was to study the reduction in frequency, duration and intensity of subsequent attacks, if any [Annexure 2], and improvement of the quality of life (QOL) of patients as evident from the WHOQOL-BREF, QOL scale.
| Materials and Methods|| |
This was a randomised open label comparative trial conducted at Regional Research Institute (H), Puri, Odisha, from October 2012 to April 2014. The Ethical Committee of CCRH approved the study protocol. Written informed consent was obtained from all the patients. The investigator engaged in the study collected all the data as per the protocol designed for this study by CCRH. Consultant Medicine specialist was engaged at the centre to assess the cases of both the intervention groups. The study had been registered in Clinical Trial Registry of India vide registration number CTRI/2011/12/002268.
All the above medicines were prescribed in consultation with the modern medicine specialist, as per the requirement of the case.
Both males and females in the age group of 15–60 years with the presence of local signs and symptoms such as pain, tenderness, local swelling and warmth in the groin with or without associated constitutional symptoms such as fever, nausea and vomiting reporting within 72 h of attack either with previous history of ADL attacks or reporting for the first time from the endemic areas were included in the study. In known cases of LF, having acute ADL, only the cases with Grade 1 and 2 lymphoedema were included in the study population [Figure 1].
Patients with any of the following criteria were excluded:
- Acute attacks of ADL with Grade III and IV lymphoedema and chronic hydrocele cases
- Lymphangitis due to
- Infection (ascending lymphangitis)
Patients suffering from diabetes mellitus, severe systemic illness, congestive cardiac failure,
- Nephrotic syndrome, malignancy and congenital lymphatic system abnormality
- Patients coming after taking any treatment for the present ADL attack
- Patients deemed unfit for participation in the study
- Patients not willing to sign the written informed consent.
Examinations and investigations
The study participants were physically examined to elicit, lymphoedema and/or local swelling, local tenderness and inflammation of the lymph nodes and lymph vessels. Inguinal, axillary or epitrochlear lymph nodes were palpated. Examinations for pitting/non-pitting oedema, skin texture, etc., and measurement of lymphoedema of the limbs at the following pre-defined points were measured.
- Upper extremity
- Upper arm
- Lower extremity
- Below knee
- Routine blood examination for haemogram including erythrocyte sedimentation rate was done at baseline and on the 11th day of follow-up.
- Night blood examination of peripheral blood for detection of circulating microfilaria was done in all the cases at entry. Immunochromatographic test for filarial antigen was done at entry.
- Routine examination of stool and urine was done.
Based on the outcome of the previous studies,,,,, the following homoeopathic medicines had been shortlisted for the homoeopathic arm in the study.
Aconite, Apis mellifica, Arnica montana, Arsenicum album, Belladonna, Bryonia alba, Calcarea carbonica, Graphites, Hepar sulphuris, Lycopodium, Medorrhinum, Merc solubilis, Natrum muriaticum., Pulsatilla, Rhus toxicodendron, Silicea, Sulphur, Thuja occidentalis and Tuberculinum.
The patients in the allopathic arm received the medicines as follows as per the requirement of the case:
- Antibiotics Cefixime/Cefadroxil for 5 days
- Anti-inflammatory drug Brufen and Paracetamol for 5 days
- Antiallergic drugs Levocetirizine for 5 days
- Antifilarial drug DEC, 1 tablet, TDS for 21 days.
The period of trial was of 18 months, including follow-up period of 6 months.
The homoeopathic medicine was prescribed based on totality of symptoms out of the pre-defined medicines.
The primary outcome : Change in ADL scores before and after treatment at baseline and on 11th day. The secondary outcome was assessed as observed from reduction in frequency, duration and intensity of subsequent attacks as per the prescribed follow-up form. QOL assessment was done using the WHOQOL-BREF QOL questionnaire in local language (Odia (http://www.who.int/mental_health/media/en/76.pdf). It was done at entry, 11 days and at completion of 6 months' treatment to assess the change in QOL of patients. Clinically improved patients were put on periodic observation till they completed 6-month follow-up for final assessment.
Each patient was assigned for either allopathic or homoeopathic medicine as intervention through random numbers obtained from www.randomizer.org.
Sample size and statistical analysis
All the analysis was done on intention to treat principle (ITT). The sample size of 112 patients including 10% drop out was finalised with assumption of effect size as 0.6 and power = 85% with 5% level of significance was recruited in the study. The sample was subjected to statistical analysis using (IBM SPSS version 20, USA). Group differences were tested using the independent t-test. Paired t-test was used to compare the results at different time points in the same group. Z-test was also used to compare two proportions.
| Results|| |
A total of 112 patients, between 15 and 60 years, presenting with local signs and symptoms of acute ADL were enrolled in the study and given either homoeopathic n = 55) or conventional treatment n = 57). Baseline characteristics of the ADL patients enrolled in both the groups were statistically insignificant. The mean age was 41.1 ± 11.1 (mean ± standard deviation [SD]) in Homoeopathy group and 40.19 ± 13.1 (mean ± SD) in allopathy group, and the majority (52%) of the study patients were female. Four patients were lost to follow-up during the 6-month study period. One patient was referred due to other serious illness in between the study period. These patients were considered for analysis through ITT. Data presented in the form of n (%), mean ± SD and P value with independent sample t-test for both the groups at baseline treatment [Table 1].
The baseline ADL scores were compared between the 1st day and 11th day of treatment for both Homoeopathy and standard allopathic intervention group. Improvement rate (pre and post treatment) was above 90% in both groups. But when both groups were compared, for the difference in ADL scores, it did not show much difference and hence the result was statistically insignificant, and both the groups were equally effective. [Table 2] and [Figure 2]. The mean ADL score during baseline to 11 days has been reduced from 11.91±2.99 (mean±sd) to 1.11±0.98 in Homoeopathy group and from 12.26±3.13 to 1.33±1.41(mean±SD) in Allopathy group [Table 2] [Figure 2]a.
|Table 2: Comparing the two groups for their efficacy at 11th Day & at 6 months|
Click here to view
Apart from the above parameter, another important aspect of the study, i.e. lymphoedema was also measured for comparison between both the groups and establishing the effectiveness of homoeopathic medicines. In the homoeopathic group, 13 out of 25 cases of Grade I lymphoedema and 21 out of 29 cases of Grade II lymphoedema improved after treatment. Twelve out of 30 cases in Grade 1 lymphoedema and 17 out of 26 cases in Grade II lymphoedema improved in allopathy group [Figure 3].
Over the follow-up period of 6 months, patients reported a total of 34 ADL episodes (16 [47.06%] –in Homoeopathy and 18 [52.94%] in – allopathy group). Intensity of attacks during 6-month period was of mild to moderate intensity in both the groups.[Table 2].
During 6 months period, In Homoeopathy group, ten (10) patients had one attack. One patient each had 2 and 4 attacks respectively. In Allopathy group, fourteen (14) patients had one attack and two patients had 2 attacks each for 6 months period.
During six months period, forty three (43) patients did not have any further episode of ADL in homoeopathy group, whereas forty one (41) patients did not have any episode of ADL in allopathy group.
Duration of the subsequent attacks were almost equal in both the groups. [Table 2].
Mean ADL score was apparently highest in cases prescribed with Apis mellifica. The prescribing indications of the medicines are given in [Table 3].
After the acute attack subsided, patients were prescribed constitutional medicines based on totality of symptoms. It was seen that seven constitutional medicines were found indicated in all. [Table 3]. Out of 23 cases of Apis mellifica, 9 cases were follow up by Natrum muriaticum, 5 by Lycopodium and 2 by Sulphur, out of 20 cases of Rhus toxicodendron, 7 cases required follow up by Sulphur whereas 5 cases were followed up with Lycopodium.
All four allopathy medicines, as per standard allopathic treatment mentioned above, were used for all allopathy group cases, as prescribed by allopathic consultant.
Secondary objective was to study the reduction in frequency, duration and intensity of subsequent attacks, if any [Annexure 2], and to assess the QOL of the patients before and after treatment. It was assessed using the WHOQOL-BREF, QOL scale questionnaire. It was used at the date of enrolment at the 11th day and at the end of 6 months of treatment to assess the change in QOL of the patients. It consists of raw score and transformed scores on a 4–20 scale and 0–100 scale, respectively. At 6 months of study, improvement in Homoeopathy group was more in Domain 4 of QOL, as compared to the allopathy group, which is also statistically significant (P = 0.004) [Table 2].
| Discussion|| |
The most distressing aspect of LF is the acute attacks of ADL, which prevent the patient from attending his daily activities. Affected individuals are estimated to lose approximately 103 million working days because of episodes of ADL and 1098 million working days because of chronic disease. Most of this time lost is in males (91%), while time loss in females is in domestic activity (83%)., This results in considerable economic loss and deterioration of QOL of the affected population.
In a study conducted in rural Odisha on treatment costs and work time loss due to episodic ADL in LF patients, it was found that patients spent INR 92/- on an average (approximately US $1.85) on each episode. The ADL episodes curtailed the productive activity of patients. Patients (88%) were unable to attend to any economic activity compared with 47% of controls who had no history of disease. Similarly, during 55% of episodes, females (vs. 8% of controls) could not attend to any domestic work. The mean number of hours spent on economic or domestic activities was significantly lower among patients. Disease status and sex had considerable influence on total absenteeism from gainful employment, and similarly, age, family type and disease status influenced total domestic work hours among women.
Hence, prompt treatment and prevention of ADL are of paramount importance.[15)
Bontha et al. assessed duration of the episode which varies from 1 to 11 days with mean duration of 3.93 (1.94 SD) days. Therefore, in this study, an 11-day study of the ADL attack was planned in the protocol.
Based on the outcome of the previous studies of CCRH, a group of pre-identified medicines was taken for the homoeopathic arm in the study.
This randomised controlled trial was first of its kind in the field of acute ADL to study the effect of homoeopathic treatment on it as compared to the modern medicine.
Comparing the baseline scores of the individual groups before and after treatment, the result were much significant. All the cases showed significant improvement in acute attacks at the 11th day of follow-up which is statistically significant, whereas when the two groups were compared with each other and statistically analysed comparing the difference in ADL scores before and after treatment, it was observed that homoeopathic medicines are equally effective as the standard modern medicines.
Another similar study  to observe the role of homoeopathic treatment in controlling the recurrent attacks of ADL, in LF, showed improvement in 70.70% patients; 276 had Grade I lymphoedema out of which total disappearance was observed in 101 patients, and in 81 patients, lymphoedema was reduced; 161 had Grade II lymphoedema which disappeared in 32 patients, and in another 63, it reduced. The results of our study also corroborate with this study.
Individualised homoeopathic medicines were used in this study revealing an equal effect as of allopathy medicines on acute ADL. The medicines prescribed during the acute attacks were based on their characteristic indications. Apis mellifica and Rhus toxicodendron, followed by Pulsatilla were the most common medicines used in the acute attacks whereas the earlier studies  showed Rhus toxicodendron, Bryonia alba, Apis mellifica and Arsenic album to be the most useful medicines. It was observed that Rhus toxicodendron was more suitable for ADL patients (n = 20) in Puri district of Odisha perhaps due to the coastal climatic conditions, which is also one of the causative modalities of this medicine.
No statistically significant difference was found between the effect of Homoeopathy and allopathy treatment on ADL. However, this study yielded a positive outcome through Homoeopathy. It is proved that Homoeopathy medicines are equally effective in ADL attacks as allopathy medicines.
ADL attacks were controlled and lymphoedema disappeared or reduced. This is in conformation with the findings in the earlier studies.
But to get a more significant and better result, a multicentric research with larger samples is essential with different approach, i.e. immunological studies on filariasis so that the scientificity of Homoeopathy can be established.
| Conclusion|| |
Despite all the differences, the overall conclusion from the above study can be drawn that Homoeopathy is equally effective as conventional therapy in the treatment of acute ADL. This work has certainly contributed to the growing evidence that Homoeopathy is a safe and better treatment strategy and is at par with standard allopathic therapy in the above condition. This work has made our study hypothesis true that when prescribed upon totality of symptoms, Homoeopathy is equally useful in relieving the symptoms of ADL when compared to conventional allopathic therapy. But to get a more significant result, a multicentric research with larger samples is essential with different approach, i.e. immunological studies on filariasis so that the scientificity of Homoeopathy can be established. Future researches exploring the effect of homoeopathic medicines on the filarial antigens using Og4C3 ELISA test (highly specific and sensitive for the diagnosis of filariasis) or lymphoscintigraphy (which helps to access the structural and functional changes in the lymphatics) should be performed to validate the results.
The authors are thankful to Dr. Alok Kumar, former Director General in-charge, and Dr. Anil Khurana, Deputy Director General, CCRH, for their guidance in carrying out the project. We are extremely thankful to Dr. Varanasi Roja, Research Officer (S-2), CCRH HQ, for her enormous and valuable help in analysing this study. We are thankful to Mrs. Maya Padmanabhan, Statistical Assistant, CCRH, for her help in statistical analysis of the study. Last but not the least, we are thankful to all the patients for their participation in the study.
Financial support and sponsorship
The study has been funded by CCRH, an autonomous organization under the Ministry of AYUSH, Government of India.
Conflicts of interest
| References|| |
Shenoy RK. Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol 2008;46:119-25.
Agrawal VK, Sashindran VK. Lymphatic filariasis in India: Problems, challenges and new initiatives. Med J Armed Forces India 2006;62:359-62.
Babu BV, Nayak AN, Dhal K. Epidemiology of episodic adenolymphangitis: A longitudinal prospective surveillance among a rural community endemic for bancroftian filariasis in coastal Orissa, India. BMC Public Health 2005;5:50.
Kumara Swami V. The clinical manifestations of lymphatic filariasis. In: Nutman Thomas B, editor. Lymphatic Filariasis: Tropical Medicine Science and Practice. Vol. 1. London: Imperial College Press; 2000. p. 103-25.
World Health Organization. Lymphatic Filariasis: Disease and its Control. Fifth Report of the WHO Expert Committee on Filariasis. Geneva: World Health Organization; 1992. p. 8.
Krishna Kumari A, Harichandrakumar KT, Das LK, Krishnamoorthy K. Physical and psychosocial burden due to lymphatic filariasis as perceived by patients and medical experts. Trop Med Int Health 2005;10:567-73.
Ramaiah KD, Das PK, Michael E, Guyatt H. The economic burden of lymphatic filariasis in India. Parasitol Today 2000;16:251-3.
Ramaiah KD, Ramu K, Guyatt H, Kumar KN, Pani SP. Direct and indirect costs of the acute form of lymphatic filariasis to households in rural areas of Tamil Nadu, South India. Trop Med Int Health 1998;3:108-15.
Sabesan A, Krishnamoorthy K, Pani SP, Panicker KN. Man, days lost due to repeated acute attacks of Lymphatic filariasis. Trends Life Sci 1992;7:5-7.
Gyapong JO, Gyapong M, Adjei S. The epidemiology of acute adenolymphangitis due to lymphatic filariasis in Northern Ghana. Am J Trop Med Hyg 1996;54:591-5.
Mishra N. Synopsis of Research publications of CCRH on LF. Monograph on Lymphatic filariasis. CCRH, New Delhi, 2010.
Mishra N, Murthy GSN, Bhanumurthy K, Mal PC, Ramesh D, Ghosh SK, et al
. Filariasis. Clinical Resaerch Series I. New Delhi: CCRH Publication; 2008. p. 53-66.
Subramanyam VR, Mishra N, Rai Y, Rakshit G, Pattnaik NM. Homoeopathic treatment of filariasis – Experience in an Indian rural setting. Br Homoeopath J 1990;79:157-60.
Rastogi DP, Mishra N. Clinical research in filariasis. CCRH Quarterly Bulletin 1991;13:1-4.
Hoti SL, Elango A, Radjame K, Yuvaraj J, Pani SP. Detection of day blood filarial antigens by og4C3 ELISA test using filter paper samples. Natl Med J India 2002;15:263-6.
Anitha K, Shenoy RK. Treatment of lymphatic filariasis: Current trends. Indian J Dermatol Venereol Leprol 2001;67:60-5.
] [Full text]
Babu BV, Nayak AN. Treatment costs and work time loss due to episodic adenolymphangitis in lymphatic filariasis patients in rural communities of Orissa, India. Trop Med Int Health 2003;8:1102-9.
Mishra N. Research studies in Filaria. CCRH Quarterly Bulletin 1998;20:22-5.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]